Abstract
Meeting abstracts Early stage detection of cancer is the key to provide a better outcome for therapeutic intervention. Proteomic technologies hold recently great promise in the search of new clinical biomarkers for the early detection and diagnosis of cancer or for the development of new vaccines
Highlights
Stage detection of cancer is the key to provide a better outcome for therapeutic intervention
Proteomics approaches towards early detection and diagnosis of ovarian cancer Ali Tiss1*, John Timms2, Usha Menon2, Alex Gammerman3, Rainer Cramer4
We will present our recent work in improving early diagnosis of ovarian cancer (OC) by combining MS analysis of serum peptidome with data collected over a period of 7 years from the United Kingdom Collaborative Trial of Ovarian Cancer Screening
Summary
Stage detection of cancer is the key to provide a better outcome for therapeutic intervention. Proteomics approaches towards early detection and diagnosis of ovarian cancer Ali Tiss1*, John Timms2, Usha Menon2, Alex Gammerman3, Rainer Cramer4 From Updates on Immunotherapy of Cancer and Immunoscore Symposium, part of the Sidra Symposia Series, held in partnership with the Society for Immunotherapy of Cancer Doha, Qatar.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
